HomeNEU • ASX
add
Neuren Pharmaceuticals Ltd
Nakaraang pagsara
$11.56
Sakop ng araw
$11.36 - $11.72
Sakop ng taon
$8.61 - $24.00
Market cap
1.47B AUD
Average na Volume
813.92K
P/E ratio
10.74
Dividend yield
-
Primary exchange
ASX
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 96.25M | 13.90% |
Gastos sa pagpapatakbo | 1.16M | -19.81% |
Net na kita | 67.01M | 22.65% |
Net profit margin | 69.62 | 7.69% |
Kita sa bawat share | — | — |
EBITDA | 87.55M | 15.88% |
Aktuwal na % ng binabayarang buwis | 21.67% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 222.24M | -2.76% |
Kabuuang asset | 409.71M | 65.22% |
Kabuuang sagutin | 45.80M | 7.11% |
Kabuuang equity | 363.90M | — |
Natitirang share | 127.01M | — |
Presyo para makapag-book | 4.03 | — |
Return on assets | 53.42% | — |
Return on capital | 60.15% | — |
Cash Flow
Net change in cash
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 67.01M | 22.65% |
Cash mula sa mga operasyon | 4.63M | -93.38% |
Cash mula sa pag-invest | 1.65M | 102.01% |
Cash mula sa financing | -5.21M | -513.40% |
Net change in cash | 291.00K | 102.73% |
Malayang cash flow | 54.95M | 14.10% |
Tungkol
CEO
Itinatag
2001
Website
Mga Empleyado
8
